Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Ovarian Neoplasms 9Endometrial Neoplasms 4Uterine Cervical Neoplasms 3Peritoneal Neoplasms 3Fallopian Tube Neoplasms 2Carcinoma, Ovarian Epithelial 2Uterine Neoplasms 1Ovarian Cysts 1Obesity, Morbid 1Genital Diseases, Female 1Endometrial Adenocarcinoma 1Colorectal Neoplasms 1Adnexal Diseases 1

Interventions

Carboplatin 159Paclitaxel 153Bevacizumab 85Taxes 48Gemcitabine 48liposomal doxorubicin 47Topotecan 41Cisplatin 35pembrolizumab 33Cyclophosphamide 27olaparib 25Immunoglobulin G 24Disulfides 24Specimen Handling 21Drug Therapy 20Docetaxel 20niraparib 18Magnetic Resonance Spectroscopy 18Doxorubicin 17Biopsy 15mirvetuximab soravtansine 14Hyperthermic Intraperitoneal Chemotherapy 14rucaparib 13Nivolumab 12Cytoreduction Surgical Procedures 11Chemotherapy, Adjuvant 10Albumin-Bound Paclitaxel 10veliparib 9Platinum 9Neoadjuvant Therapy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Fallopian Tube Neoplasms × Laparoscopy × Gynecologic × Clear all
NCT03378128 2022-03-14

MIID-SOC

Case Comprehensive Cancer Center

Phase NA Completed
50 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00002538 2013-08-20

Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers

GOG Foundation

Phase 2 Completed
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡